Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/26/2005CN1686143A Hendecanoic acid testosterone self emulsified soft capsule composition and its preparation method
10/26/2005CN1686142A Zine glycyrrhizale film for treating oral sore and its preparation method
10/26/2005CN1686141A Medicinal composition for treating hepatitis and diabetes
10/26/2005CN1686140A Valacyclovir hydrochloride freeze dried preparation and its preparation method
10/26/2005CN1686139A Application of ketosolin in new type analgesic for treatig inflammatory pain
10/26/2005CN1686138A 雷替曲塞乳剂组合物 Raltitrexed emulsion composition
10/26/2005CN1686137A Methionine vitamin B1 freeze dried composition and its preparation method
10/26/2005CN1686136A Vollikongzole preparation and its preparation method
10/26/2005CN1686135A Copmosition of popatyltamo and butyl spiro cyclic ketone
10/26/2005CN1686134A Nimustine brain slow release implantation agent and its preparation method
10/26/2005CN1686133A Soft capsule medicinal preparation
10/26/2005CN1686132A Nicergoline drip pill and its preparation method
10/26/2005CN1686131A Application of fugillin in treating immunity entiritis and related immunity disease
10/26/2005CN1686130A Application of cucoline in treating retina nerve degeneration kind disease
10/26/2005CN1686129A Cepharanthine drip pill and its preparation method
10/26/2005CN1686128A Domperidone drip pill and its preparation method
10/26/2005CN1686127A Injection use-powder ampoule for inhibiting thrombocyte agglutination and its preparation method
10/26/2005CN1686126A Milianone freeze dried preparation
10/26/2005CN1686125A Rogelinone drip pill and its preparation method
10/26/2005CN1686124A Ao meilazole sodium injection liquid
10/26/2005CN1686123A Pyrolidone hydrochloride drip pill and its preparation method
10/26/2005CN1686122A Maleic acid levo amido chloro diping oral disintegration tablet and its preparation method
10/26/2005CN1686121A Phenylsulfonic acid amido chloro diping dispersion tablet and its preparation method
10/26/2005CN1686120A Hydrobromic acid high tortoiseshell component drip pill and its preparation method
10/26/2005CN1686119A Compound herba fibraureae recisea freeze dried powder injection agent, its preparation method and application
10/26/2005CN1686118A Tiemozolenium brain slow release implantation agent and its preparation method
10/26/2005CN1686117A Application of levoornidazole in preparation of anti anaerobic bacteria infection medicine
10/26/2005CN1686116A Levo ornidazole vein administration agent and its preparation method
10/26/2005CN1686115A Indole-3-methanol and its dimer application in preparation of medicnie for preventing and treating bred blood vessel disease
10/26/2005CN1686114A Enteric migelinai agent and its preparation method
10/26/2005CN1686113A Medicinal composition for lowering blood fat and its application
10/26/2005CN1686112A Use of cnidicin and preparation used for treating fatty liver
10/26/2005CN1686111A Ginkgo lactone injection agent and its preparation method
10/26/2005CN1686110A Picropodophyllin and its derivative emulsified composition
10/26/2005CN1686109A Application of cantharidin derivative as anti-tumour medicine
10/26/2005CN1686108A Andrographolide fatty microglobule agent and its preparation method
10/26/2005CN1686107A Acetyl salicyl sulfonone oral cavity disintegration tablet and its preparation method
10/26/2005CN1686106A Rabdosia rubescens A microglobule medicinal agent and its preparation method
10/26/2005CN1686105A Danshinone II A sodium sulphonate freeze dried powder injection agent and its preparation method
10/26/2005CN1686104A Tanshinone solid dispersion, inclusion compound and its use
10/26/2005CN1686103A Medicinal composition containing tanshinon II A sodium sulfonate and its quality control method
10/26/2005CN1686102A Application of cantharidin derivative in preparation of antitumour medicine
10/26/2005CN1686101A New use of linolenic acid in preparation of anti arthrolithiasis medicine or health care food
10/26/2005CN1686100A Sodium thio pronine medicinal composition used for treating acute and chronic hepatitis
10/26/2005CN1686099A Thiopronine aseptic powder injection agent
10/26/2005CN1686098A Thiopronine freeze dried powder injection agent
10/26/2005CN1686097A Freeze dried composition containing thiopronin and its preparation method
10/26/2005CN1686096A Nimeishuli drip pill and its preparation method
10/26/2005CN1686095A Toterodine drip pill and its preparation method
10/26/2005CN1686094A Tartaric acid toterodine slow released drip pill and its preparation method
10/26/2005CN1686093A Application of boisynthesized hypocrelline B in preparation of anticancer medicine
10/26/2005CN1686092A Application of biosynthesized hypocrelline A, HA in preparation of anticancer medicine
10/26/2005CN1686091A Composition of aiphenyl hepatanone compound and its use
10/26/2005CN1686090A Garlicin injection agent medicine and its preparation method
10/26/2005CN1686089A Xylitol granule capable of directly being pressed into tablet and its preparation method
10/26/2005CN1224708C i (Neisseria meningitidis) antigens
10/26/2005CN1224628C Preparation of solanine sulfurate and its use in medicine
10/26/2005CN1224626C Beta-D-5-thioxylose derivatives, preparation method and therapeutic use
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/26/2005CN1224598C Naphthalene derivatives
10/26/2005CN1224424C Thermosetting medical carrier composition with mucosa adsorption
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/26/2005CN1224420C Agent for treating visual cell function disorder
10/26/2005CN1224398C Method for preparing sealwort polysaccharide wine
10/26/2005CN1224397C Medine for curing chronic nephritis and productive technology thereof
10/26/2005CN1224396C Pharmaceutical for treating cardiovascular and cerebrovascular disease
10/26/2005CN1224395C Medical function of sophorine
10/26/2005CN1224394C Use for saponin of Chinese aralia in preparation of dysmenorrhea medicine
10/26/2005CN1224393C Process for preparing selenium aspirin enteric tablet and its use of resisting thrombosis
10/26/2005CN1224392C Use of diosgenin for preparing medicine for anti-carcinoma of stomach
10/26/2005CN1224391C Endoparasiticidal combination
10/26/2005CN1224390C Pharmaceutical composition comprising pyrroloquinoline quinone for curing and preventing fatty liver
10/26/2005CN1224389C The use of scopolamine salts
10/26/2005CN1224388C Modified prodrug forms of ap/amp
10/26/2005CN1224387C Oral preparation of Tegaserod or its acid salt and its preparing process
10/26/2005CN1224386C Fumagucin injection against cancers and its preparing method
10/26/2005CN1224385C Medicament contg. platinum complex compounds and use thereof
10/26/2005CN1224384C Dysuria remedies
10/26/2005CN1224383C Blood sugar reducing compound
10/26/2005CN1224382C Method for preparing medicine for relieving cough and reducing sputum
10/26/2005CN1224380C Method for reducing residual organic solvent in microparticles and use in preparation of medicine thereof
10/26/2005CN1224376C Skin care cosmetic compositions containing carboxymethylates of branched alcohols and/or ethoxylates thereof
10/25/2005US6958411 Antitumor agent; viricide
10/25/2005US6958399 Compounds capable of activating cholinergic receptors
10/25/2005US6958396 8-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-methyl-4H-Benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site
10/25/2005US6958386 MUM-1 protein expressed by multiple myeloma-related gene
10/25/2005US6958359 administering vanadium cyclopentadienyl complexes; vandocene acetylacetonate; preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury; antitumor, antiproliferative agents
10/25/2005US6958358 Inhibitors of cruzipain and other cysteine proteases
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958354 Pyrazole compounds as transforming growth factor (TGF) inhibitors
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958351 NMDA NR2B antagonists for treatment
10/25/2005US6958350 Chemical compounds
10/25/2005US6958349 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/25/2005US6958348 Side effect reduction
10/25/2005US6958346 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
10/25/2005US6958345 syn-N1-(2-hydroxymethylcyclopropylidenemethyl)-cytosine for example; treating HIV, herpes viruses, Epstein-Barr virus (EBV), hepatitis B virus
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
1 ... 4493 4494 4495 4496 4497 4498 4499 4500 4501 4502 4503 4504 4505 4506 4507 4508 4509 4510 4511 4512 4513 ... 7860